Indeed, an initial short treatment of experimental IBD with analogue 5 increased the number of MLN Foxp3 + CD4 + CD25 + Treg cells and the gene expression of colonic FoxP3, as well as inducing tolerance to colitis recurrence. Here, CD4 is linked to inflammatory bowel disease.